Erectile Dysfunction and cardiovascular risk factors in a Mediterranean diet cohort

Erectile dysfunction (ED) affects more than 100 million men worldwide, with a wide variability in prevalence. An overall association of cardiovascular risk factors, lifestyle and diet in the context of ED in a Mediterranean population is lacking.

To assess ED prevalence and associated factors in a Mediterranean cohort of non-diabetic patients with cardiovascular risk factors.

Observational, cross-sectional study of patients aged over 40 treated at cardiovascular risk units in Catalonia. Anthropometric data, risk factors, lifestyle and diet habits were recorded. ED was assessed using the International Index of Erectile Function.

440 patients included, 186 (42. 3%) with ED (24. 8% mild, 6. 8% moderate and 10. 7% severe). ED presence and severity were associated with age, obesity, waist circumference, hypertension, antihypertensive treatment and ischemic disease. Patients with ED were more frequently smokers, sedentary and consumed more alcohol. In multivariate analysis, consumption of nuts (> twice a week) (OR 0. 41 [95% CI 0. 25 to 0. 67] and vegetables (≥ once a day) (OR 0. 47 [95% CI 0. 28 - 0,77]), were inversely related to ED. Obesity (as BMI ≥ 30 kg/m(2) ) (OR 2. 49 [95% CI 1. 48 -4. 17]), ischemic disease (OR 2. 30 [95% CI 1. 22 to 4. 33], alcohol consumption (alcohol-units a day) (OR 1. 14 [95% CI 1. 04 to 1. 26], and age (year) (OR = 1. 07 [95% CI 1. 04-1. 10] were directly related to ED.

ED is a common disorder in patients treated in lipid units in Catalonia for cardiovascular risk factors. This condition is associated with age, obesity, ischemic disease and unhealthy lifestyle habits.

Internal medicine journal. 2015 Oct 20 [Epub ahead of print]

Rafael Ramirez, Juan Pedro-Botet, Montserrat Garcia, Emili Corbella, Jordi Merino, Daniel Zambón, Xavier Corbella, Xavier Pintó, Xarxa de Unitats de Lípids i Arteriosclerosi (XULA) investigators group

Hypertension, Dyslipidemia and Vascular Risk Unit, Department of Internal Medicine, Hospital de Sant Pau i Santa Tecla, Tarragona, Spain. , Lipids and Vascular Risk Unit, Internal Medicine Service, Hospital del Mar, Barcelona, Spain. , Internal Medicine Service, Capio Hospital General de Catalunya, San Cugat del Vallès, Barcelona, Spain. , Internal Medicine Department, Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona, CIBERobn ISCIII, Spain. , Vascular Medicine and Metabolism Unit, Lipids and Atherosclerosis Research Unit, IISPV, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Reus, Spain. , Lipid Clinic, Endocrinology Division, Hospital Clinic, Barcelona, Spain. , Internal Medicine Department, Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona, CIBERobn ISCIII, Spain. , Internal Medicine Department, Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona, CIBERobn ISCIII, Spain.

PubMed